This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Aguero-Rosenfeld M.E., Wang G., Swartz I., Wormer G.P.: Diagnosis of Lyme borreliosis. Clin. Microbiol. Rev.18, 484–509 (2005)10.1128/CMR.18.3.484-509.2005119597016020686Search in Google Scholar
Ates L., Hansen-Hübner C., Norris D.E. Richter D., Kraiczy P., Hunfeld K.-P.: Comparison of in vitro activities of tigecycline, doxycycline, and tetracycline against the spirochete Borreliaburgdorferi. Ticks Tick Borne Dis.1, 30–34 (2010)Search in Google Scholar
BrouquiP., Badiaga S., Raoult D.: Eucaryotic cells protect Borrelia burgdorferi from the action of penicillin and ceftriaxone but not from the action of doxycycline and erythromycin. Anti- microb. Agents Chemother. 40, 1552–1554 (1996)10.1128/AAC.40.6.15521633688726038Search in Google Scholar
Chmielewski T., Tylewska-Wierzbanowska S.: Interaction between Borrelia burgdorferi and mouse fibroblasts. Pol. J. Microbiol. 59, 157–160 (2010)Search in Google Scholar
Comstock L.E., Thomas D.D.: Penetration of endothelial cell monolayers by Borrelia burgdorferi. Infect. Immun.57, 1626– 1628 (1989)10.1128/iai.57.5.1626-1628.19893133252707862Search in Google Scholar
Feng J., Wang T., Shi W., Zhang S., Sullivan D., Auwaerter P. G., Zhang Y.: Identification of novel activity against Borrelia burgdorferipersisters using an FDA approved drug library. Emerg. Microbes Infect. 3, e49 (2014)10.1038/emi.2014.53412618126038747Search in Google Scholar
Feng J., Auwaerter P.G., Zhang Y.: Drug combination against Borrelia burgdorferipersisters in vitro: eradication achieved by using daptomycin, cefoperazone and doxycycline. PLoS ONE, 10, e0117207 (2015)10.1371/journal.pone.0117207437381925806811Search in Google Scholar
Feng J., Zhang S., Shi W., Zhang Y.: Ceftriaxone pulse dosing fails to eradicate bio-like microcolonyB. burgdorferi persisters which are sterilized by daptomycin/doxycycline/cefuroxime without pulse dosing. Front. Microbiol.7, 1744 (2016)10.3389/fmicb.2016.01744509512427867375Search in Google Scholar
Hunfeld K.-P., Kraiczy P., Wichelhause T.A., Schäfer V., Brade V.: Colorimetric in vitro susceptibility testing of penicillins, cephalosporins, macrolides, streptogramins, tetracyclines, and aminoglicosides against Borrelia burgdorferi isolates. Intern. J. Med. Microbiol. 15, 11–17 (2000)Search in Google Scholar
Hunfeld K.-P., Brade V.: Antimicrobial susceptibility of Borrelia burgdorferi sensulato: what we know, what we don’t known, and what we need to know. Wien. Klin. Wochenschr.22, 659–668 (2006)10.1007/s00508-006-0693-z17160604Search in Google Scholar
Hunfeld K.-P., Ruzic-Subljic E., Norris D. E., Kraiczy P., Strle F.: In vitro susceptibility testing of Borrelia burgdorferisensulato isolates cultured from patients with erythema migrans before and after antimicrobial chemotherapy. Antimicrob. Agents Chemother. 49, 1294–1301 (2005)10.1128/AAC.49.4.1294-1301.2005106861215793100Search in Google Scholar
Hunfeld K.-P., Ruzic-Subljic E., Norris D. E., Kraiczy P., Strle F.: Risk of culture-confirmed borrelial persistence in patients treated for erythema migrans and possible mechanisms of resistance. Intern. J. Med. Microbiol. 296 Suppl. 40, 233–241 (2006)Search in Google Scholar
Kraiczy P., Weigand J., Wichelhaus T. A., Heising P., Backes H., Schafer V., Acker G., Brade V., Hunfeld K.-P.: In vitro activities of fluorochinolones against the spirochete Borrelia burgdorferi. Antimcrob. Agents Chemiother. 45, 2486–2494 (2001)10.1128/AAC.45.9.2486-2494.20019068211502519Search in Google Scholar
Morgenstern K., Bajler G., Norris D. E., Kraiczy P., Hanssen-Hübner C., Hunfeld K.-P.: In vitro susceptibility of Borreliaspielmanii to microbial agents commonly used for treatment of Lyme disease. Antimicrob. Agents Chemother. 53, 1281–1284 (2009)10.1128/AAC.01247-08265057019075048Search in Google Scholar
Obonyo M., Munderloch U. G., Fingerle V., Wilske B., Kurtti T.J.: Borrelia burgdorferi in tick cell culture modulates expression of outer surface proteins A and C in response to temperature. J. Clin. Microbiol.37, 2137–2141 (1999)10.1128/JCM.37.7.2137-2141.1999Search in Google Scholar
Tylewska-Wierzbanowska S., Chmielewski T.: The isolation of Borrelia burgdorferi spirochetes from clinical material in cel line cultures. Zbl. Bakt.286, 363–370 (1997)10.1016/S0934-8840(97)80094-1Search in Google Scholar
Veinovic G., Cerar T., Strle F., Lotric-Furlan S., Maraspin V., Cimperman J., Ruzic-Sabljic E.: In vitro susceptibility of European human Borrelia burgdorferi sensustricto strains to antimicrobial agents. Int. J. Antimicrob. Agents, 41, 288–291 (2013)10.1016/j.ijantimicag.2012.11.01623312603Search in Google Scholar
